high-throughput sequencing services
The procurement contact named on the official notice.
https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f Access documents via the above link
The submission route named on the official notice.
The primary aim of this procurement is to secure a high-throughput sequencing service provider to perform sequencing services for the Cell and Gene Therapy (CGT) Catapult on a fee-per-service basis.
This service will support the CGT Catapult's mission of accelerating the commercialization of innovation from research and overcoming technical barriers in advanced therapy medicinal product (ATMP) development.
The selected provider's services will complement CGT Catapult's unique technical facilities and expertise at its London site.
This procurement seeks comprehensive high-throughput sequencing services.
These services will be utilized for deep process characterization, particularly for processes like stem cell differentiation and viral vector manufacturing.
The required services include, but are not limited to: Lot 1 - High-throughput short-read sequencing of libraries generated by CGT Catapult (i.e., sequencing only) Lot 2 - Bulk RNA sequencing Lot 3 - Bulk small RNA sequencing Lot 4 - Single-cell RNA sequencing (scRNA-seq) of cryopreserved/fixed samples Lot 5 - AAV genome short-read sequencing Lot 6 - Sanger sequencing
What the supplier must deliver
This service will support the CGT Catapult's
This service will support the CGT Catapult's mission of accelerating the commercialization of innovation from research and overcoming technical barriers in advanced therapy medicinal product (ATMP) development.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at CELL THERAPY CATAPULT LIMITED, and generate a go-to-market strategy from their news, accounts and people.
The full intelligence dossier
Our agent reads CELL THERAPY CATAPULT LIMITED’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-058ffe
- Stage
- tender · Open
- Source
- Find a Tender
- Buyer ref
- 052281-2025
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Research & Development
CELL THERAPY CATAPULT LIMITED’s tender network
Assembling the network…